ID   SOX9_RAT                Reviewed;         507 AA.
AC   F1LYL9;
DT   17-JUN-2020, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2013, sequence version 2.
DT   24-JUL-2024, entry version 95.
DE   RecName: Full=Transcription factor SOX-9 {ECO:0000305};
GN   Name=Sox9 {ECO:0000312|RGD:620474};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, AND DNA-BINDING.
RX   PubMed=26150426; DOI=10.1093/nar/gkv688;
RA   Liu C.F., Lefebvre V.;
RT   "The transcription factors SOX9 and SOX5/SOX6 cooperate genome-wide through
RT   super-enhancers to drive chondrogenesis.";
RL   Nucleic Acids Res. 43:8183-8203(2015).
CC   -!- FUNCTION: Transcription factor that plays a key role in chondrocytes
CC       differentiation and skeletal development (By similarity). Specifically
CC       binds the 5'-ACAAAG-3' DNA motif present in enhancers and super-
CC       enhancers and promotes expression of genes important for
CC       chondrogenesis, including cartilage matrix protein-coding genes COL2A1,
CC       COL4A2, COL9A1, COL11A2 and ACAN, SOX5 and SOX6 (PubMed:26150426). Also
CC       binds to some promoter regions (By similarity). Plays a central role in
CC       successive steps of chondrocyte differentiation (By similarity).
CC       Absolutely required for precartilaginous condensation, the first step
CC       in chondrogenesis during which skeletal progenitors differentiate into
CC       prechondrocytes (By similarity). Together with SOX5 and SOX6, required
CC       for overt chondrogenesis when condensed prechondrocytes differentiate
CC       into early stage chondrocytes, the second step in chondrogenesis (By
CC       similarity). Later, required to direct hypertrophic maturation and
CC       block osteoblast differentiation of growth plate chondrocytes:
CC       maintains chondrocyte columnar proliferation, delays prehypertrophy and
CC       then prevents osteoblastic differentiation of chondrocytes by lowering
CC       beta-catenin (CTNNB1) signaling and RUNX2 expression (By similarity).
CC       Also required for chondrocyte hypertrophy, both indirectly, by keeping
CC       the lineage fate of chondrocytes, and directly, by remaining present in
CC       upper hypertrophic cells and transactivating COL10A1 along with MEF2C
CC       (By similarity). Low lipid levels are the main nutritional determinant
CC       for chondrogenic commitment of skeletal progenitor cells: when lipids
CC       levels are low, FOXO (FOXO1 and FOXO3) transcription factors promote
CC       expression of SOX9, which induces chondrogenic commitment and
CC       suppresses fatty acid oxidation (By similarity). Mechanistically,
CC       helps, but is not required, to remove epigenetic signatures of
CC       transcriptional repression and deposit active promoter and enhancer
CC       marks at chondrocyte-specific genes (By similarity). Acts in
CC       cooperation with the Hedgehog pathway-dependent GLI (GLI1 and GLI3)
CC       transcription factors (By similarity). In addition to cartilage
CC       development, also acts as a regulator of proliferation and
CC       differentiation in epithelial stem/progenitor cells: involved in the
CC       lung epithelium during branching morphogenesis, by balancing
CC       proliferation and differentiation and regulating the extracellular
CC       matrix (By similarity). Controls epithelial branching during kidney
CC       development (By similarity). {ECO:0000250|UniProtKB:Q04887,
CC       ECO:0000269|PubMed:26150426}.
CC   -!- SUBUNIT: Homodimer; homodimerization is required for activity.
CC       Interacts (via C-terminus) with ZNF219; forming a complex that binds to
CC       the COL2A1 promoter and activates COL2A1 expression (By similarity).
CC       Interacts with DDRGK1. Interacts with EP300/p300 (By similarity).
CC       Interacts with beta-catenin (CTNNB1); inhibiting CTNNB1 activity by
CC       competing with the binding sites of TCF/LEF within CTNNB1 (By
CC       similarity). {ECO:0000250|UniProtKB:P48436,
CC       ECO:0000250|UniProtKB:Q04887}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q04887,
CC       ECO:0000255|PROSITE-ProRule:PRU00267}.
CC   -!- DOMAIN: The transactivation domains TAM and TAC (for transactivation
CC       domain in the middle and at the C-terminus, respectively) are required
CC       to contact transcriptional coactivators and basal transcriptional
CC       machinery components and thereby induce gene transactivation.
CC       {ECO:0000250|UniProtKB:P48436}.
CC   -!- DOMAIN: The 9aaTAD motif is a transactivation domain present in a large
CC       number of yeast and animal transcription factors.
CC       {ECO:0000250|UniProtKB:P48436}.
CC   -!- DOMAIN: The PQA region (for proline, glutamine and alanine-rich) helps
CC       stabilize SOX9 and facilitates transactivation. It lacks intrinsic
CC       transactivation capability. {ECO:0000250|UniProtKB:P48436}.
CC   -!- PTM: Acetylated; acetylation impairs nuclear localization and ability
CC       to transactivate expression of target genes. Deacetylated by SIRT1.
CC       {ECO:0000250|UniProtKB:Q04887}.
CC   -!- PTM: Phosphorylation at Ser-64 and Ser-211 by PKA increases
CC       transcriptional activity and may help delay chondrocyte maturation
CC       downstream of PTHLH/PTHrP signaling. Phosphorylation at either Ser-64
CC       or Ser-211 is required for sumoylation, but phosphorylation is not
CC       dependent on sumoylation. Phosphorylated on tyrosine residues; tyrosine
CC       dephosphorylation by PTPN11/SHP2 blocks SOX9 phosphorylation by PKA and
CC       subsequent SUMOylation. {ECO:0000250|UniProtKB:Q04887}.
CC   -!- PTM: Sumoylated; phosphorylation at either Ser-64 or Ser-211 is
CC       required for sumoylation. Sumoylation is induced by BMP signaling
CC       pathway. {ECO:0000250|UniProtKB:Q04887}.
CC   -!- PTM: Ubiquitinated; ubiquitination leads to proteasomal degradation and
CC       is negatively regulated by DDRGK1. {ECO:0000250|UniProtKB:Q04887}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR07030718; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473948; EDM06505.1; -; Genomic_DNA.
DR   RefSeq; NP_536328.1; NM_080403.1.
DR   AlphaFoldDB; F1LYL9; -.
DR   SMR; F1LYL9; -.
DR   STRING; 10116.ENSRNOP00000003511; -.
DR   iPTMnet; F1LYL9; -.
DR   PhosphoSitePlus; F1LYL9; -.
DR   PaxDb; 10116-ENSRNOP00000003511; -.
DR   Ensembl; ENSRNOT00000003511.7; ENSRNOP00000003511.5; ENSRNOG00000002607.7.
DR   Ensembl; ENSRNOT00055051420; ENSRNOP00055042380; ENSRNOG00055029697.
DR   Ensembl; ENSRNOT00060039050; ENSRNOP00060032286; ENSRNOG00060022513.
DR   Ensembl; ENSRNOT00065037090; ENSRNOP00065029899; ENSRNOG00065021810.
DR   GeneID; 140586; -.
DR   KEGG; rno:140586; -.
DR   AGR; RGD:620474; -.
DR   CTD; 6662; -.
DR   RGD; 620474; Sox9.
DR   eggNOG; KOG0527; Eukaryota.
DR   GeneTree; ENSGT00940000158269; -.
DR   HOGENOM; CLU_031800_0_0_1; -.
DR   InParanoid; F1LYL9; -.
DR   OMA; QSSNSYY; -.
DR   OrthoDB; 2902801at2759; -.
DR   Reactome; R-RNO-3769402; Deactivation of the beta-catenin transactivating complex.
DR   PRO; PR:F1LYL9; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Proteomes; UP000234681; Chromosome 10.
DR   Bgee; ENSRNOG00000002607; Expressed in colon and 16 other cell types or tissues.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; ISS:UniProtKB.
DR   GO; GO:0005667; C:transcription regulator complex; IDA:UniProtKB.
DR   GO; GO:0008013; F:beta-catenin binding; ISO:RGD.
DR   GO; GO:0043425; F:bHLH transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IMP:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISS:UniProtKB.
DR   GO; GO:0097157; F:pre-mRNA intronic binding; ISO:RGD.
DR   GO; GO:0034236; F:protein kinase A catalytic subunit binding; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0097065; P:anterior head development; ISO:RGD.
DR   GO; GO:0003180; P:aortic valve morphogenesis; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0060018; P:astrocyte fate commitment; ISO:RGD.
DR   GO; GO:0030282; P:bone mineralization; ISO:RGD.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; ISO:RGD.
DR   GO; GO:0060532; P:bronchus cartilage development; ISO:RGD.
DR   GO; GO:0019933; P:cAMP-mediated signaling; IDA:UniProtKB.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0001502; P:cartilage condensation; ISS:UniProtKB.
DR   GO; GO:0051216; P:cartilage development; IEP:RGD.
DR   GO; GO:0045165; P:cell fate commitment; ISO:RGD.
DR   GO; GO:0001708; P:cell fate specification; ISS:UniProtKB.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0061323; P:cell proliferation involved in heart morphogenesis; ISO:RGD.
DR   GO; GO:0098609; P:cell-cell adhesion; ISO:RGD.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0071504; P:cellular response to heparin; ISS:UniProtKB.
DR   GO; GO:0071347; P:cellular response to interleukin-1; ISO:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; ISS:UniProtKB.
DR   GO; GO:0071300; P:cellular response to retinoic acid; ISO:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; ISS:UniProtKB.
DR   GO; GO:0007417; P:central nervous system development; ISO:RGD.
DR   GO; GO:0002063; P:chondrocyte development; ISO:RGD.
DR   GO; GO:0002062; P:chondrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0003413; P:chondrocyte differentiation involved in endochondral bone morphogenesis; ISS:UniProtKB.
DR   GO; GO:0003415; P:chondrocyte hypertrophy; ISS:UniProtKB.
DR   GO; GO:0006338; P:chromatin remodeling; ISS:UniProtKB.
DR   GO; GO:0090103; P:cochlea morphogenesis; ISS:UniProtKB.
DR   GO; GO:0007010; P:cytoskeleton organization; ISO:RGD.
DR   GO; GO:0003203; P:endocardial cushion morphogenesis; ISS:UniProtKB.
DR   GO; GO:0060350; P:endochondral bone morphogenesis; ISO:RGD.
DR   GO; GO:0031018; P:endocrine pancreas development; ISO:RGD.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0050673; P:epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0060517; P:epithelial cell proliferation involved in prostatic bud elongation; ISS:UniProtKB.
DR   GO; GO:0001837; P:epithelial to mesenchymal transition; ISS:UniProtKB.
DR   GO; GO:0060441; P:epithelial tube branching involved in lung morphogenesis; ISO:RGD.
DR   GO; GO:0070371; P:ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0085029; P:extracellular matrix assembly; ISO:RGD.
DR   GO; GO:0030198; P:extracellular matrix organization; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0002067; P:glandular epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0021780; P:glial cell fate specification; ISO:RGD.
DR   GO; GO:0003430; P:growth plate cartilage chondrocyte growth; ISS:UniProtKB.
DR   GO; GO:0001942; P:hair follicle development; ISS:UniProtKB.
DR   GO; GO:0070384; P:Harderian gland development; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0003170; P:heart valve development; ISS:UniProtKB.
DR   GO; GO:0003188; P:heart valve formation; ISO:RGD.
DR   GO; GO:0003179; P:heart valve morphogenesis; ISS:UniProtKB.
DR   GO; GO:0048873; P:homeostasis of number of cells within a tissue; ISO:RGD.
DR   GO; GO:0060575; P:intestinal epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0060729; P:intestinal epithelial structure maintenance; ISS:UniProtKB.
DR   GO; GO:0035622; P:intrahepatic bile duct development; ISO:RGD.
DR   GO; GO:0032808; P:lacrimal gland development; ISO:RGD.
DR   GO; GO:0060174; P:limb bud formation; ISO:RGD.
DR   GO; GO:0060487; P:lung epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0061145; P:lung smooth muscle development; ISO:RGD.
DR   GO; GO:0019100; P:male germ-line sex determination; ISS:UniProtKB.
DR   GO; GO:0008584; P:male gonad development; ISS:UniProtKB.
DR   GO; GO:0030238; P:male sex determination; ISO:RGD.
DR   GO; GO:0030879; P:mammary gland development; ISO:RGD.
DR   GO; GO:0097152; P:mesenchymal cell apoptotic process; ISO:RGD.
DR   GO; GO:0010463; P:mesenchymal cell proliferation; ISO:RGD.
DR   GO; GO:0072289; P:metanephric nephron tubule formation; ISS:UniProtKB.
DR   GO; GO:0072170; P:metanephric tubule development; ISO:RGD.
DR   GO; GO:0061138; P:morphogenesis of a branching epithelium; ISS:UniProtKB.
DR   GO; GO:0002009; P:morphogenesis of an epithelium; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:1904864; P:negative regulation of beta-catenin-TCF complex assembly; ISO:RGD.
DR   GO; GO:0070168; P:negative regulation of biomineral tissue development; ISS:UniProtKB.
DR   GO; GO:0030502; P:negative regulation of bone mineralization; ISO:RGD.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISS:UniProtKB.
DR   GO; GO:0032331; P:negative regulation of chondrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0030857; P:negative regulation of epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; ISS:UniProtKB.
DR   GO; GO:0046322; P:negative regulation of fatty acid oxidation; ISS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0002683; P:negative regulation of immune system process; ISS:UniProtKB.
DR   GO; GO:2001054; P:negative regulation of mesenchymal cell apoptotic process; ISO:RGD.
DR   GO; GO:1902894; P:negative regulation of miRNA transcription; ISO:RGD.
DR   GO; GO:0045662; P:negative regulation of myoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0030279; P:negative regulation of ossification; ISS:UniProtKB.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0046533; P:negative regulation of photoreceptor cell differentiation; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0014032; P:neural crest cell development; ISO:RGD.
DR   GO; GO:0048665; P:neuron fate specification; ISO:RGD.
DR   GO; GO:0007219; P:Notch signaling pathway; ISO:RGD.
DR   GO; GO:0030903; P:notochord development; ISO:RGD.
DR   GO; GO:0006334; P:nucleosome assembly; ISS:UniProtKB.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; ISO:RGD.
DR   GO; GO:0001503; P:ossification; ISO:RGD.
DR   GO; GO:0071599; P:otic vesicle development; ISO:RGD.
DR   GO; GO:0030916; P:otic vesicle formation; ISS:UniProtKB.
DR   GO; GO:0043491; P:phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB.
DR   GO; GO:0061036; P:positive regulation of cartilage development; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:2000138; P:positive regulation of cell proliferation involved in heart morphogenesis; ISO:RGD.
DR   GO; GO:0032332; P:positive regulation of chondrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:1902732; P:positive regulation of chondrocyte proliferation; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0030858; P:positive regulation of epithelial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0010634; P:positive regulation of epithelial cell migration; ISS:UniProtKB.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; ISS:UniProtKB.
DR   GO; GO:1901203; P:positive regulation of extracellular matrix assembly; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0090184; P:positive regulation of kidney development; ISS:UniProtKB.
DR   GO; GO:2000020; P:positive regulation of male gonad development; ISS:UniProtKB.
DR   GO; GO:0002053; P:positive regulation of mesenchymal cell proliferation; ISS:UniProtKB.
DR   GO; GO:2000741; P:positive regulation of mesenchymal stem cell differentiation; ISS:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0045732; P:positive regulation of protein catabolic process; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:2000648; P:positive regulation of stem cell proliferation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0030850; P:prostate gland development; ISO:RGD.
DR   GO; GO:0060512; P:prostate gland morphogenesis; ISO:RGD.
DR   GO; GO:0034504; P:protein localization to nucleus; ISO:RGD.
DR   GO; GO:0065003; P:protein-containing complex assembly; ISS:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0061046; P:regulation of branching involved in lung morphogenesis; ISO:RGD.
DR   GO; GO:0030155; P:regulation of cell adhesion; ISO:RGD.
DR   GO; GO:0010564; P:regulation of cell cycle process; ISS:UniProtKB.
DR   GO; GO:0045595; P:regulation of cell differentiation; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0060784; P:regulation of cell proliferation involved in tissue homeostasis; ISS:UniProtKB.
DR   GO; GO:2000794; P:regulation of epithelial cell proliferation involved in lung morphogenesis; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0072034; P:renal vesicle induction; ISS:UniProtKB.
DR   GO; GO:0070542; P:response to fatty acid; ISS:UniProtKB.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0060041; P:retina development in camera-type eye; ISS:UniProtKB.
DR   GO; GO:0060221; P:retinal rod cell differentiation; ISS:UniProtKB.
DR   GO; GO:0060009; P:Sertoli cell development; IEP:UniProtKB.
DR   GO; GO:0060008; P:Sertoli cell differentiation; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; ISS:UniProtKB.
DR   GO; GO:0001501; P:skeletal system development; ISS:UniProtKB.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; ISS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB.
DR   GO; GO:0072089; P:stem cell proliferation; ISO:RGD.
DR   GO; GO:0001894; P:tissue homeostasis; ISS:UniProtKB.
DR   GO; GO:0060534; P:trachea cartilage development; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0060509; P:type I pneumocyte differentiation; ISO:RGD.
DR   GO; GO:0072189; P:ureter development; ISO:RGD.
DR   GO; GO:0072197; P:ureter morphogenesis; ISO:RGD.
DR   GO; GO:0072193; P:ureter smooth muscle cell differentiation; ISO:RGD.
DR   GO; GO:0072190; P:ureter urothelium development; ISO:RGD.
DR   CDD; cd22031; HMG-box_SoxE; 1.
DR   Gene3D; 1.10.30.10; High mobility group box domain; 1.
DR   InterPro; IPR009071; HMG_box_dom.
DR   InterPro; IPR036910; HMG_box_dom_sf.
DR   InterPro; IPR022151; Sox_N.
DR   InterPro; IPR050917; SOX_TF.
DR   PANTHER; PTHR45803; SOX100B; 1.
DR   PANTHER; PTHR45803:SF1; TRANSCRIPTION FACTOR SOX-9; 1.
DR   Pfam; PF00505; HMG_box; 1.
DR   Pfam; PF12444; Sox_N; 1.
DR   SMART; SM00398; HMG; 1.
DR   SUPFAM; SSF47095; HMG-box; 1.
DR   PROSITE; PS50118; HMG_BOX_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Differentiation; DNA-binding; Isopeptide bond;
KW   Nucleus; Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..507
FT                   /note="Transcription factor SOX-9"
FT                   /id="PRO_0000450217"
FT   DNA_BIND        105..173
FT                   /note="HMG box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00267"
FT   REGION          1..67
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          63..103
FT                   /note="Dimerization (DIM)"
FT                   /evidence="ECO:0000250|UniProtKB:P48436"
FT   REGION          63..103
FT                   /note="PQA"
FT                   /evidence="ECO:0000250|UniProtKB:P48436"
FT   REGION          160..271
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          224..307
FT                   /note="Transactivation domain (TAM)"
FT                   /evidence="ECO:0000250|UniProtKB:P48436"
FT   REGION          335..429
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          392..507
FT                   /note="Transactivation domain (TAC)"
FT                   /evidence="ECO:0000250|UniProtKB:P48436"
FT   REGION          477..507
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           275..284
FT                   /note="9aaTAD 1"
FT                   /evidence="ECO:0000250|UniProtKB:P48436"
FT   MOTIF           290..298
FT                   /note="9aaTAD 2"
FT                   /evidence="ECO:0000250|UniProtKB:P48436"
FT   MOTIF           458..466
FT                   /note="9aaTAD 3"
FT                   /evidence="ECO:0000250|UniProtKB:P48436"
FT   COMPBIAS        18..52
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        160..187
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        188..233
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        339..367
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        368..429
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        482..507
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         64
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q04887"
FT   MOD_RES         211
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q04887"
FT   CROSSLNK        396
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q04887"
SQ   SEQUENCE   507 AA;  56124 MW;  0EF0A9E4733D48AB CRC64;
     MNLLDPFMKM TDEQEKGLSG APSPTMSEDS AGSPCPSGSG SDTENTRPQE NTFPKGEPDL
     KKESEEDKFP VCIREAVSQV LKGYDWTLVP MPVRVNGSSK NKPHVKRPMN AFMVWAQAAR
     RKLADQYPHL HNAELSKTLG KLWRLLNESE KRPFVEEAER LRVQHKKDHP DYKYQPRRRK
     SVKNGQAEAE EATEQTHISP NAIFKALQAD SPHSSSGMSE VHSPGEHSGQ SQGPPTPPTT
     PKTDVQAGKV DLKREGRPLA EGGRQPPIDF RDVDIGELSS DVISNIETFD VNEFDQYLPP
     NGHPGVPATH GQVSYTGSYG ISSTAPTPAT AGHVWMSKQQ APPPPPQQPP QAPQAPQAPP
     QQQAPPQPQQ APQQQQAHTL TTLSSEPGQS QRTHIKTEQL SPSHYSEQQQ HSPQQISYSP
     FNLPHYNPSY PTITRSQYDY TDHQNSGSYY SHAAGQGSGL YSTFTYMNPA QRPMYTPIAD
     TSGVPSIPQT HSPQHWEQPV YTQLTRP
//
